Correct Answer: D. Eczema or lipodermatosclerosis may develop
Chronic venous insufficiency (CVI) in the lower limbs progresses through a well-defined spectrum of cutaneous and subcutaneous changes. The correct answer identifies the pathological sequelae that develop as CVI advances. Lipodermatosclerosis and eczema are hallmark complications of advanced chronic venous disease, representing the natural progression of venous hypertension on skin and subcutaneous tissues. Lipodermatosclerosis occurs due to chronic inflammation, fibrosis of subcutaneous fat, and dermal thickening—manifesting as a characteristic "inverted champagne bottle" appearance of the lower leg. Venous eczema (also called gravitational or stasis dermatitis) develops from chronic edema, impaired lymphatic drainage, and inflammatory mediator accumulation, presenting with pruritus, erythema, and scaling. These are not rare complications but rather expected manifestations of long-standing CVI. According to Bailey & Love and standard Indian surgical practice, patients with chronic venous changes should be counseled about these skin changes as part of natural disease progression. The presence of these findings indicates advanced disease and warrants intervention to prevent further deterioration and venous ulceration.
Why the other options are wrong
A. Sclerotherapy is preferred — This is wrong because sclerotherapy is indicated for telangiectasia and small varicose veins, not for chronic venous changes with established skin complications. In advanced CVI with lipodermatosclerosis and eczema, the underlying pathology is deep venous insufficiency or perforator incompetence requiring surgical intervention (ligation, stripping, or endovenous ablation), not sclerotherapy. Sclerotherapy would be inadequate and inappropriate for the severity of disease implied by skin changes. B. Venous ulcer not expected — This is wrong because venous ulcers are a common and expected complication of chronic venous insufficiency, particularly when lipodermatosclerosis and eczema are already present. These skin changes represent the precursor stage to ulceration. The presence of lipodermatosclerosis significantly increases the risk of venous ulcer formation. This option contradicts the natural history of CVI and would dangerously mislead clinical management. C. Telangiectasia is uncommon — This is wrong because telangiectasia is actually very common in chronic venous disease and represents one of the earliest visible signs of venous insufficiency. Dilated capillaries and small venules are frequently observed in CVI patients. This option reverses the epidemiology of cutaneous manifestations and may trap students who confuse telangiectasia with lipodermatosclerosis (which is less common but more specific for advanced disease).
High-Yield Facts
- Lipodermatosclerosis is a hallmark of advanced CVI, characterized by fibrosis and induration of subcutaneous fat, creating an 'inverted champagne bottle' leg appearance.
- Venous eczema (stasis dermatitis) develops in CVI due to chronic edema, impaired lymphatic drainage, and inflammatory mediator accumulation, presenting with pruritus and scaling.
- CEAP classification (Clinical, Etiological, Anatomical, Pathophysiological) grades CVI: C0 (no signs), C1 (telangiectasia), C2 (varicose veins), C3 (edema), C4 (skin changes: eczema/lipodermatosclerosis), C5 (healed ulcer), C6 (active ulcer).
- Lipodermatosclerosis significantly increases venous ulcer risk—patients with this finding require aggressive compression therapy and consideration for surgical intervention.
- Sclerotherapy is contraindicated in advanced CVI with skin changes; it is reserved for telangiectasia and small varicose veins without deep insufficiency.
Mnemonics
CEAP for CVI Progression C0→C1→C2→C3→C4→C5→C6: Clinical severity increases from no signs (C0) through telangiectasia (C1), varicose veins (C2), edema (C3), skin changes like eczema/lipodermatosclerosis (C4), healed ulcer (C5), to active ulcer (C6). Use this to remember that skin changes (eczema, lipodermatosclerosis) are C4—advanced but not yet ulcerated. Lipodermatosclerosis = Lipid + Dermal + Sclerosis Remember: fibrosis of subcutaneous FAT (lipo-) + SKIN inflammation (-derma-) + HARDENING (-sclerosis). This triple pathology creates the inverted champagne bottle leg. Use when visualizing the pathophysiology.
NBE Trap
NBE may trap students by pairing "chronic venous changes" with "sclerotherapy" (Option A), exploiting the common misconception that sclerotherapy treats all varicose vein manifestations. Additionally, students unfamiliar with the CEAP classification may incorrectly assume that skin changes are rare (Option C) or that ulcers are unexpected (Option B), missing the natural progression of CVI.
Clinical Pearl
In Indian clinical practice, many patients with chronic venous disease present late with established lipodermatosclerosis and eczema due to delayed diagnosis and poor compliance with compression therapy. Recognition of these skin changes should prompt urgent intervention—compression stockings (Class III–IV), leg elevation, and consideration for surgical intervention—to prevent progression to venous ulceration, which is socially disabling and difficult to heal in resource-limited settings.
_Reference: Bailey & Love Ch. 57 (Venous Disorders); Robbins Ch. 11 (Hemodynamic Disorders)_